Membership Committee
The Membership Committee works to build bridges within the multidisciplinary GI clinician community to facilitate networking to collaborate with SAIA to improve patient care, host professional events, and advance research. This committee is led by Dr. Reezwana Chowdhury, MD, FACG.
SAIA’s Membership Committee is led by Reezwana Chowdhury, MD, FACG.
Read Dr. Reezwana Chowdhury's Bio
Reezwana Chowdhury, MD, FACG is an Assistant Professor of Medicine at Johns Hopkins School of Medicine. She is an Inflammatory Bowel Disease Specialist, with a focus on women’s health and pregnancy and interest in intestinal bowel ultrasound. She is the Director of the upcoming Intestinal Bowel Ultrasound program at Johns Hopkins and the Director of the ‘Well-Being and Resilience’ committee of the Gastroenterology and Hepatology Division at Johns Hopkins. She has published articles on Pregnancy and women’s health in Inflammatory Bowel Disease. She is the Chair of the Public Relations Committee for the American College of Gastroenterology, actively involved with the ASGE and a member of the Inflammatory Bowel Disease special interest group. She serves as an Associate Editor of the journal, Crohn’s & Colitis 360. She has effectively combined her passion for patient care, colorectal cancer awareness and running to organize several patient-physician events to enhance public awareness around CRC.
Dr. Priya Sehgal serves as SAIA’s Events Liaison.
Read Dr. Priya Sehgal's Bio
Priya Sehgal, MD, MS, MPH is an Assistant Professor of Medicine and the Director of the GI Center for Weight Wellness & Inflammatory Diseases at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania.
She completed her medical degree at the Icahn School of Medicine at Mount Sinai, followed by an Internal Medicine residency at Mount Sinai Hospital and a Gastroenterology fellowship at Columbia University Irving Medical Center. During her fellowship, she was awarded an NIH T32 training grant and earned a Master’s in Patient-Oriented Research. She also holds a Master of Public Health in Health Policy from the Harvard T.H. Chan School of Public Health and completed an Advanced IBD Fellowship at the University of Pennsylvania.
Dr. Sehgal has a particular interest in the impact of obesity on IBD outcomes. She currently serves as the site principal investigator for multiple Phase 3 and 4 clinical trials evaluating novel biologics for Crohn’s diseases and ulcerative colitis.